Plasma Derived Product Market Report 2025 (Global Edition)

Global Plasma Derived Product Market Report 2025 Market Size Split by Product Type (Albumin, Coagulation factors, Immunoglobulins, Others), by Indication (Bleeding Disorders, Immune Deficiencies, Auto...

Plasma Derived Product Market Report Description

We have various report editions of Plasma Derived Product Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Plasma Derived Product Market Insights Video

Competitive Landscape of the Plasma Derived Product Market

The plasma-derived product industry is highly competitive, with significant competitors including CSL Behring, Grifols, and Takeda Pharmaceuticals. These companies dominate because of superior technologies and diverse product portfolios that include immunoglobulins, clotting factors, and albumin. Continuous innovation, smart acquisitions, and worldwide growth initiatives fuel market competition. Additionally, players make significant investments in research and development to improve product efficacy and safety. New entrants and regional competitors are also developing, increasing competition and driving further breakthroughs in plasma-based therapeutics.

May 2023: PlasmaGen Biosciences has opened a new blood plasma product manufacturing plant in Kolar with the goal of increasing production capacity and meeting India's growing demand for plasma-derived medicines.

(Source: https://www.biospectrumindia.com/news/90/23161/plasmagen-biosciences-opens-new-manufacturing-facility-for-blood-plasma-products-in-kolar.html)

Top Companies Market Share in Plasma Derived Product Industry: (In no particular order of Rank)

• CSL Behring (Australia)
• Takeda Pharmaceutical Company Limited. (Japan)
• Biotest AG (Germany)
• Octapharma (Switzerland)
• BPL (India)
• ADMA Biologics (United States)
• Grifols
• Kedrion (United States)
• Kamada Pharmaceuticals (Israel)
• SK Plasma (South Korea)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Plasma Derived Product Market

Which Region Dominates the Plasma Derived Product Market in 2024?

According to Cognitive Market Research, North America will dominate the plasma-derived product market by 2024 due to its advanced healthcare infrastructure, high prevalence of chronic and autoimmune illnesses, and significant presence of prominent pharmaceutical companies. The region benefits from well-established plasma donor networks and cutting-edge manufacturing technology, which help to provide a consistent supply of high-quality plasma-derived medicines. Furthermore, considerable investments in R&D and favorable regulatory environments contribute to market growth. These characteristics contribute to North America's leadership in the global plasma-derived product industry, driving both innovation and consumption.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is experiencing the fastest CAGR growth in the plasma-derived product market. Increased healthcare investments are driving this rapid growth, the rising prevalence of chronic diseases, and the expansion of healthcare infrastructure in emerging nations. This growth is fueled by the region's increased knowledge of plasma donation, as well as advancements in medical technology. As countries such as China and India improve their healthcare systems and regulatory frameworks, they are becoming key players in the plasma-derived product industry, accelerating growth and attracting global investment.

 

The current report Scope analyzes Plasma Derived Product Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Plasma Derived Product Market Analysis

According to Cognitive Market Research, the global Plasma Derived Product market size was estimated at USD 17241.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 6896.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Plasma Derived Product market with a market size of USD 5441.32 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The plasma-derived product market in the United States is expanding because of improved healthcare infrastructure, high disease prevalence, and large R&D investments.
• The Canada Plasma Derived Product market had a market share of USD 827.58 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. In Canada, market growth is being driven by increased healthcare investments, expanded plasma donation networks, and growing awareness of plasma-derived medicines.
• The Mexico Plasma Derived Product market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 627.58 million in 2024.

Europe Plasma Derived Product Market Analysis

According to Cognitive Market Research, the global Plasma Derived Product market size was estimated at USD 17241.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 5172.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031.

• The United Kingdom Plasma Derived Product market had a market share of USD 868.96 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. The plasma-derived product market in the United Kingdom is expanding due to improved healthcare facilities, rising demand for specialized therapies, and major investments in medical research.
• The France Plasma Derived Product market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 475.86 million in 2024.
• According to Cognitive Market Research, the Germany Plasma Derived Product market size was valued at USD 1024.13 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. A robust healthcare infrastructure, an increase in the prevalence of chronic diseases, and widespread support for plasma donation and processing technology drive market expansion in Germany.
• The Italy Plasma Derived Product market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 444.82 million in 2024.
• The Russia Plasma Derived Product market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 801.72 million in 2024.
• The Spain Plasma Derived Product market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 424.13 million in 2024
• The Luxembourg Plasma Derived Product market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 160.34 million in 2024.
• The Portugal Plasma Derived Product market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 108.62 million in 2024.
• The Greece Plasma Derived Product market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 62.07 million in 2024.
• The Rest of Europe's Plasma Derived Product market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 801.72 million in 2024.

Asia Pacific Plasma Derived Product Market Analysis

According to Cognitive Market Research, the global Plasma Derived Product market size was estimated at USD 17241.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 3965.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Plasma Derived Product market size was valued at USD 1784.46 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. China's plasma-derived product market is being pushed by developing healthcare infrastructure, rising prevalence of chronic diseases, and increased investment in plasma collecting and processing technology.
• The Japan Plasma Derived Product market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 547.24 million in 2024.
• The India Plasma Derived Product market had a market share of USD 475.86 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. Rising healthcare investments, expanded plasma donation networks, and more public awareness of plasma-derived medicines are all driving market expansion in India.
• The South Korea Plasma Derived Product market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 396.55 million in 2024.
• The Australia Plasma Derived Product market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 206.20 million in 2024.
• The South East Asia Plasma Derived Product market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 273.62 million in 2024.
• The Rest of Asia Pacific Plasma Derived Product market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 281.55 million in 2024.

South America Plasma Derived Product Market Analysis

According to Cognitive Market Research, the global Plasma Derived Product market size was estimated at USD 17241.2 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 862.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Plasma Derived Product market size was valued at USD 368.96 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. The expansion of healthcare infrastructure, the rising frequency of chronic diseases, and increased plasma donation and processing capacities are all driving growth in Brazil's plasma-derived product industry.
• Argentina Plasma Derived Product market had a market share of USD 144.83 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In Argentina, market expansion is being driven by increased healthcare spending, increased awareness of plasma-derived medicines, and improved plasma collection and processing infrastructure.
• Colombia Plasma Derived Product market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 76.72 million in 2024.
• Peru Plasma Derived Product market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 70.69 million in 2024.
• Chile Plasma Derived Product market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 62.07 million in 2024.
• The Rest of Latin America Plasma Derived Product market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 138.79 million in 2024.

Middle East Plasma Derived Product Market Analysis

According to Cognitive Market Research, the global Plasma Derived Product market size was estimated at USD 17241.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 344.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

• The GCC Countries Plasma Derived Product market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 147.58 million in 2024. The expansion of healthcare infrastructure, increased investments in medical technologies, and rising demand for sophisticated therapies are driving the plasma-derived product market in GCC countries.
• The Egypt Plasma Derived Product market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 36.21 million in 2024.
• The South Africa Plasma Derived Product market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 54.48 million in 2024. In South Africa, market expansion is being driven by increased healthcare investment, improved plasma donation and processing capacities, and increased knowledge of plasma-based therapies.
• The Turkey Plasma Derived Product market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 29.65 million in 2024.
• The Nigeria Plasma Derived Product market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 36.21 million in 2024.
• The Rest of MEA Plasma Derived Product market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 40.69 million in 2024.

Plasma Derived Product Market Analysis

Plasma Derived Product Market Product Type Segment Analysis

According to Cognitive Market Research, Immunoglobulins are the largest product segment in the worldwide plasma-derived products market. The increasing prevalence of immunological deficiencies and autoimmune illnesses, which require immunoglobulin therapy for successful management, is driving this segment's rise. Furthermore, advances in immunoglobulin production technology and increased healthcare access are fueling the growing demand for these goods. Their vital function in treating a variety of chronic diseases and infections ensures their continued market dominance.

Coagulation factors are the fastest expanding category of the worldwide plasma-derived product market. This expansion is being driven by the increased prevalence of hemophilia and other bleeding disorders that necessitate particular coagulation factor therapy. Improved treatment choices and manufacturing process innovations are increasing product efficacy and availability. Furthermore, increased awareness and improved identification of coagulation disorders are driving higher acceptance rates for these medicines, hastening their market rise.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Plasma Derived Product Industry. Request a Free Sample PDF!

Indication Segment Analysis of Plasma Derived Product Market

This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.

Some of the key Indication of Plasma Derived Product are:

• Bleeding Disorders
• Immune Deficiencies
• Autoimmune and Inflammatory Diseases
• Congenital Deficiency Disorders
• Other

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Plasma Derived Product Distribution Channel Segment Analysis

Distribution Channel Segment Analysis

According to Cognitive Market Research, Hospital Pharmacies are the largest distribution channel in the global plasma-derived product market. The enormous amount of plasma-derived products necessary for treating patients in hospitals, particularly for critical and chronic illnesses, drives the segment's growth. Hospital pharmacies play an important role in managing complex medicines and assuring the availability of specialized plasma-based products. Their integrated healthcare services and ability to manage big amounts of such products help them maintain their market dominance.

Online pharmacies are the fastest-growing component of the worldwide plasma-derived product market. This expansion is due to the growing use of e-commerce platforms and the convenience of online ordering for both patients and healthcare providers. Online pharmacies provide a more efficient purchase process and increased access to plasma-derived products, especially in remote or underdeveloped locations. The expanding popularity of digital health solutions, as well as the growing inclination for home delivery services, are propelling rapid growth in this segment.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion